Resmed Inc filed 2 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-08-17. Between them they name 3 people, with 2 appointments and 2 departures. Each change below is quoted from the filing and linked to it.
Every change, newest first
Departing: Ronald Taylor, Director
On August 13, 2026, Ronald Taylor, a director of Resmed, informed the Board that he will not stand for election at Resmed's 2026 annual meeting of stockholders (the "Annual Meeting") and intends to retire from the Board, effective at the Annual Meeting, which is expected to be held on November 18, 2026.
Departing: Brett Sandercock, Chief Financial Officer
On April 30, 2026, ResMed Inc. (the "Company") announced that Brett Sandercock, Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, will retire from his role as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer.
Appointed: Aaron Bloomer, Chief Financial Officer, effective 2026-05-04
On April 30, 2026, the Company also announced it appointed Aaron Bloomer, age 40, as Chief Financial Officer, effective May 4, 2026.
Appointed: Aaron Bloomer, Principal Financial Officer
Mr. Bloomer will serve as our Principal Financial Officer and Principal Accounting Officer.
Find people with the same kind of experience as the Director at Resmed Inc, with the record behind each one.
Find candidates like Director at Resmed IncNew leaders review vendors and budgets in their first months. Get an alert the next time Resmed Inc is in the news or changes leadership.
Get an alert when Resmed Inc changes leadershipTools for this story
Each opens in a new tab, filled in for Resmed Inc. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.